| Cover | Sep. 28, 2023 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Sep. 28, 2023 |
| Entity File Number | 000-54478 |
| Entity Registrant Name | Renovaro Biosciences Inc. |
| Entity Central Index Key | 0001527728 |
| Entity Tax Identification Number | 45-2559340 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 2080 Century Park East |
| Entity Address, Address Line Two | Suite 906 |
| Entity Address, City or Town | Los Angeles |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 90067 |
| City Area Code | (305) |
| Local Phone Number | 918-1980 |
| Written Communications | true |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | ENOB |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
